Notable Analyst Rating Changes 7/1: (GSK) (WRI) (GEL) Upgraded; (CVRR) (SWKS) (AVY) Downgraded
Tweet Send to a Friend
UPGRADES
Citi upgrades GlaxoSmithKline (NYSE: GSK) from Neutral to Buy.UBS lifts Weingarten (NYSE: WRI) from Neutral to Buy and moves ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi upgrades GlaxoSmithKline (NYSE: GSK) from Neutral to Buy.UBS lifts Weingarten (NYSE: WRI) from Neutral to Buy and moves ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE